Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 239-360-0 | CAS number: 15323-35-0
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Endpoint summary
Administrative data
Key value for chemical safety assessment
Genetic toxicity in vitro
Description of key information
The test substance is not mutagenic in any of the tests performed (Ames (2x), micronucleus assay, chromosome aberration test, SOS chromotest).
Link to relevant study records
- Endpoint:
- in vitro gene mutation study in bacteria
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- guideline study
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 471 (Bacterial Reverse Mutation Assay)
- Qualifier:
- according to guideline
- Guideline:
- EU Method B.13/14 (Mutagenicity - Reverse Mutation Test Using Bacteria)
- GLP compliance:
- yes
- Type of assay:
- bacterial reverse mutation assay
- Specific details on test material used for the study:
- - Test substance storage: At room temperature in the dark
- Description: Off white solid
- Expiry date: 19 January 1999
- Stability in vehicle: at least 96 hours in ethanol - Species / strain / cell type:
- S. typhimurium TA 1535, TA 1537, TA 98 and TA 100
- Species / strain / cell type:
- E. coli WP2 uvr A
- Metabolic activation:
- with and without
- Metabolic activation system:
- Aroclor 1254 induced rat liver S9 homogenate
- Test concentrations with justification for top dose:
- Experiment 1a: 3, 10, 33, 100, 333, 1000, 3330, 5000 µg/plate (TA100, WP2uvrA)
Experiment 1b: 10, 33, 100, 333, 1000 µg/plate (TA 1535, TA 1537, TA98)
Experiment 2: 10, 33, 100, 333, 1000 µg/plate (All strains) - Vehicle / solvent:
- ethanol
- Untreated negative controls:
- no
- Negative solvent / vehicle controls:
- yes
- True negative controls:
- no
- Positive controls:
- yes
- Positive control substance:
- 4-nitroquinoline-N-oxide
- 9-aminoacridine
- sodium azide
- methylmethanesulfonate
- other: Daunomycine
- Details on test system and experimental conditions:
- METHOD OF APPLICATION: in agar (plate incorporation)
DURATION
- Exposure duration: 48 hours
NUMBER OF REPLICATIONS: 3
DETERMINATION OF CYTOTOXICITY
- Method: reduction of the bacterial background lawn, the increase in the size of the microcolonies and the reduction of the revertant colonies - Evaluation criteria:
- Acceptability of the assay: A Salmonella typhimurium reverse mutation assay and/or Escherichia coli reverse mutation assay is considered acceptable if it meets the following criteria: a) The negative control data (number of spontaneous revertants per plate) should be within the laboratory historical range for each tester strain. b) The positive control chemicals should produce responses in all tester strains, which are within the laboratory historical range documented for each positive control substance. Furthermore, the mean plate count should be at least two times the concurrent vehicle control group mean. c) The selected dose range should include a clearly toxic concentration or should exhibit limited solubility as demonstrated by the preliminary toxicity range-finding test or should extend to 5 mg/plate.
Data evaluation: A test substance is considered negative (not mutagenic) in the test if: a) The total number of revertants in any tester strain is not greater than two (2) times the solvent control, with or without metabolic activation b) The negative response should be reproducible in at least one independently repeated experiment. A test substance is considered positive (mutagenic) in the test if: a) It induces at least 2-fold, dose related increase in the number of revertants with respect to the number induced by the solvent control in any of the tester strains, either with or without metabolic activation. However, any mean plate count of less than 20 is considered to be not significant. b) The positive response should be reproducible in at least one independently repeated experiment. - Key result
- Species / strain:
- S. typhimurium TA 1535
- Metabolic activation:
- with and without
- Genotoxicity:
- negative
- Cytotoxicity / choice of top concentrations:
- cytotoxicity
- Vehicle controls validity:
- valid
- Untreated negative controls validity:
- not examined
- Positive controls validity:
- valid
- Key result
- Species / strain:
- S. typhimurium TA 1537
- Metabolic activation:
- with and without
- Genotoxicity:
- negative
- Cytotoxicity / choice of top concentrations:
- cytotoxicity
- Vehicle controls validity:
- valid
- Untreated negative controls validity:
- not examined
- Positive controls validity:
- valid
- Key result
- Species / strain:
- S. typhimurium TA 98
- Metabolic activation:
- with and without
- Genotoxicity:
- negative
- Cytotoxicity / choice of top concentrations:
- cytotoxicity
- Vehicle controls validity:
- valid
- Untreated negative controls validity:
- not examined
- Positive controls validity:
- valid
- Key result
- Species / strain:
- S. typhimurium TA 100
- Metabolic activation:
- with and without
- Genotoxicity:
- negative
- Cytotoxicity / choice of top concentrations:
- cytotoxicity
- Vehicle controls validity:
- valid
- Untreated negative controls validity:
- not examined
- Positive controls validity:
- valid
- Key result
- Species / strain:
- E. coli WP2 uvr A
- Metabolic activation:
- with and without
- Genotoxicity:
- negative
- Cytotoxicity / choice of top concentrations:
- cytotoxicity
- Vehicle controls validity:
- valid
- Untreated negative controls validity:
- not examined
- Positive controls validity:
- valid
- Additional information on results:
- Dose range finding test:
- The test substance precipitated in the top agar at concentrations of 333 µg/plate and upwards. Precipitation of the test substance on the plates was observed at the start and at the end of the incubation period at concentrations of 1000 µg/plate and upwards in tester strain TA100 and WP2uvrA.
- In tester strain WP2uvrA, no reduction of the bacterial background lawn and no decrease in the number of revertants was observed. In tester strain TA100, no reduction of the bacterial background lawn was observed. In the absence of S9-mix, a reduction in the number of revertant colonies was observed at concentrations of 333 µg/plate and upwards, which was less than the minimal value of the historical control data range. In the presence of S9-mix, a reduction in the number of revertant colonies was observed at concentrations of 1000 µg/plate and upwards.
Mutation assay:
- The test substance precipitated in the top agar at concentrations of 333 and 1000 µg/plate. Precipitation of the test substance on the plates was observed at the start and at the end of the incubation period at the concentration of 1000 µg/plate in all tester strains.
- In tester strain TA100, a reduction in the number of revertant colonies was observed at the concentration of 1000 µg/plate, which was less than the minimal value of the historical control data range. In the other strains, no clear decrease in the number of revertants was observed. The bacterial background lawn was not reduced at all concentrations tested.
Number of revertants
- All bacterial strains showed negative responses over the entire dose range, i.e. no dose-related, two-fold, increase in the number of revertants in two independently repeated experiments. The strain-specific positive control values were within our laboratory background historical control data ranges indicating that the test conditions were adequate and that the metabolic activation system functioned properly. The negative control values were within our laboratory background historical control data ranges, except for WP2uvrA (first experiment). However, since these values were just outside the limit of the range, the validity of the test was considered not to be affected.
Reference
Endpoint conclusion
- Endpoint conclusion:
- no adverse effect observed (negative)
Genetic toxicity in vivo
Endpoint conclusion
- Endpoint conclusion:
- no study available
Additional information
Ames
In a bacterial reverse mutation assay, performed according to OECD Guideline 471 and following GLP, the test substance was tested with four histidine-requiring strains of Salmonella typhimurium (TA1535, TA1537, TA98 and TA100) and a tryptophan-requiring strain of Escherichia coli (WP2uvrA). The test was performed in two independent experiments in the presence and absence of S9-mix (rat liver S9-mix induced by Aroclor 1254). The test substance was dissolved in ethanol. In the dose range finding test, the test substance was tested up to concentrations of 5000 μg/plate in the absence and presence of S9-mix in tester strain TA100 and WP2uvrA. The test substance precipitated in the top agar at concentrations of 333 µg/plate and upwards. Precipitation of the test substance on the plates was observed at the start and at the end of the incubation period at concentrations of 1000 µg/plate and upwards in tester strain TA100 and WP2uvrA. In tester strain WP2uvrA, no reduction of the bacterial background lawn and no decrease in the number of revertants was observed. In tester strain TA100, no reduction of the bacterial background lawn was observed. In the absence of S9-mix, a reduction in the number of revertant colonies was observed at concentrations of 333 µg/plate and upwards, which was less than the minimal value of the historical control data range. In the presence of S9-mix, a reduction in the number of revertant colonies was observed at concentrations of 1000 µg/plate and upwards. Based on the results of the dose range finding test, the test substance was tested in the first mutation assay at a concentration range of 10 to 1000 μg/plate in the absence and presence of S9-mix in tester strains TA1535, TA1537 and TA98. In an independent repeat of the assay, the test substance was tested at the same concentration range as the first assay in the absence and presence of S9 -mix in all tester strains. The test substance precipitated in the top agar at concentrations of 333 and 1000 µg/plate. Precipitation of the test substance on the plates was observed at the start and at the end of the incubation period at the concentration of 1000 µg/plate in all tester strains. In tester strain TA100, a reduction in the number of revertant colonies was observed at the concentration of 1000 µg/plate, which was less than the minimal value of the historical control data range. In the other strains, no clear decrease in the number of revertants was observed. The bacterial background lawn was not reduced at all concentrations tested. Based on the results of this study it is concluded that the test substance is not mutagenic in the Salmonella typhimurium reverse mutation assay and in the Escherichia coli reverse mutation assay.
In a publication by Mersch-Sundermanno (1998), the test substance was tested in the Salmonella typhimurium reverse mutation assay (plate-incorporation) with four strains of Salmonella typhimurium (TA97, TA98, TA100 and TA102). The test substance was dissolved in DMSO. The test was performed in triplicate in the presence and absence of S9-mix (rat liver S9-mix induced by Aroclor 1254). The strains were exposed to 0, 5, 16.6, 50, 166.6, and 500 µg/plate. The maximum concentration was chosen considering the limit of solubility of the compounds in the aqueous medium of the assays. In the present study the test substance did not show a mutagenic effect using the Salmonella/mammalian mutagenicity assay.
Chromosome aberration test
In a chromosome aberration test, performed in accordance with OECD Guideline 473 and following GLP, Chinese hamster lung (CHL) cells were exposed to the test substance in the presence and absence of a metabolic activation system. In the absence of S9-mix, the test substance was tested up to 42 µg/mL for a 24 h treatment/fixation time and up to 33 µg/mL for a 48 h treatment/fixation time in the first experiment. In the second experiment, the test substance was tested up to 33 µg/mL for a 24 h treatment/fixation time. In the presence of 8% (v/v) S9-fraction the test substance was tested up to 33 µg/mL for both a 3 h treatment time with a 24 h fixation time and a 3 h treatment time with a 48 h fixation time in the first experiment. In the second experiment, the test substance was tested up to 24 µg/mL for a 3 h treatment time with a 24 h fixation time. Positive control chemicals, mitomycin C and Cyclophosphamide, both produced a statistically significant increase in the incidence of cells with chromosome aberrations, indicating that the test conditions were adequate and that the metabolic activation system functioned properly. In the absence of S9-mix statistically significant increases in the number of cells with chromosome aberrations were observed at concentrations of 18 and 33 µg/mL at the 24 h treatment/fixation time in the first experiment. Since, the types of aberrations observed were mainly breaks and gaps, the increases are not dose-related, the second experiment did not confirm this result and moreover the number of cells with chromosome aberrations are still within the historical control data range these increases are considered not biologically relevant. In the presence of S9-mix a statistically significant increase in the number of cells with chromosome aberrations was observed at the concentration of 33 µg/mL at the 3 h treatment time with a 24 h fixation time in the first experiment. Since, the types of aberrations observed were mainly breaks and gaps, the increase is not dose-related, the second experiment did not confirm this result and moreover the number of cells with chromosome aberrations are still within our historical control data range this increase is considered not biologically relevant. Finally, it is concluded that this test should be considered valid and that the test substance is not clastogenic under the experimental conditions of this test.
Micronucleus assay
In a publication by Kevekordes (1997), the test substance was examined in vitro in a micronucleus test using human lymphocytes in the presence and absence of rat liver S9 and using human hepatoma cell line Hep G2 (metabolic system not required). The test concentrations used were up to the toxic concentrations. No genotoxicity in the micronucleus test with human lymphocytes and with the human hepatoma cell line Hep G2 was observed.
SOS chromotest
In a publication by Mersch-Sundermanno (1998), the test substance was tested in the Escherichia coli PQ37 genotoxicity assay (SOS chromotest). The test substance was dissolved in DMSO. The test was performed in quadruplicate in the presence and absence of S9-mix (rat liver S9-mix induced by Aroclor 1254). The E. Coli was exposed to 0, 0.39, 0.78, 1.56, 3.125, 6.25, 12.5, 25, and 50 µg/assay. The maximum concentration was chosen considering the limit of solubility of the compounds in the aqueous medium of the assays. In the present study the test substance did not show SOS inducing potency.
Justification for classification or non-classification
The test substance does not have to be classified for mutagenicity according to Regulation (EC) No 1272/2008.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.